Beginning July 1, 2026, the Medicare GLP-1 Bridge Program may allow eligible Medicare Part D patients to access certain obesity-indicated GLP-1 medications, including Foundayo, Wegovy, and certain Zepbound formulations, for no more than $50 per month through December 31, 2027
Dr Steward said the rise in off-label prescribing is concerning but the results here should still be enough to ring alarm bells
Borovcanin, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Challenging when appetite is suppressed and youre eating 1,200-1,800 calories
To prevent muscle loss on GLP-1 injections, you must prioritize two things: adequate protein intake (aim for 0.8 to 1.0 grams of protein per pound of target body weight) and consistent, progressive resistance training
